Del. lawmakers look to hold companies accountable for opioid crisis
In Delaware, lawmakers are considering a few pieces of legislation that look to curb the opioid epidemic.
One of those bills is expected to go in front of the Senate Wednesday afternoon.
Senate bill 176 looks to hold pharmaceutical companies accountable for their role in the opioid crisis by placing a quarterly fee on drug manufacturers. That money would then be used to fund treatment for substance abuse.
Senator Stephanie Hansen, the sponsor of the bill, calls the piece of legislation controversial, but necessary to make a dent on this public health crisis.
"This affects nearly everyone in the state in some way, that you may not even know. You may have someone in your family that had a problem with opioids," says Sen. Hansen.